In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants (Q40414595)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2005
edit
Language Label Description Also known as
English
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants
scientific article published on June 2005

    Statements

    In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants (English)
    Thomas O'Hare
    Denise K Walters
    Eric P Stoffregen
    Taiping Jia
    Paul W Manley
    Jürgen Mestan
    Sandra W Cowan-Jacob
    Francis Y Lee
    Michael W N Deininger
    1 June 2005
    4500-4505

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit